Literature DB >> 9066674

Effects of interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma.

N H Obata1, K Tamakoshi, K Shibata, F Kikkawa, Y Tomoda.   

Abstract

High levels of IL-6 have been observed in ascitic fluid in patients with ovarian cancer. In this study, we examined the effects of IL-6 on in vitro invasiveness of human ovarian cancer cells. Human ovarian cancer cells, NOM1 and SKOV, were used. Cell attachment to Matrigel, migration, and invasion were examined with or without IL-6. Zymography was performed to analyze gelatinase production by these cells. NOM1 cell attachment was increased by IL-6 (0 to 10 ng/ml). In a migration assay, IL-6 ranging from 0 to 10 ng/ml showed chemotactic and/or chemokinetic activities for the two cell lines. The invasiveness of these cells was significantly enhanced by IL-6 at the above concentrations. However, IL-6 did not modulate the production of either MMPs or TIMPs. IL-6 affects cell invasion through its effects on attachment and migration in human ovarian cancer cells. IL-6 might thus contribute to the progression of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9066674

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  33 in total

1.  Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.

Authors:  Monique B Nilsson; Robert R Langley; Isaiah J Fidler
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 2.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

3.  The role of dysregulated glucose metabolism in epithelial ovarian cancer.

Authors:  L D Kellenberger; J E Bruin; J Greenaway; N E Campbell; R A Moorehead; A C Holloway; J Petrik
Journal:  J Oncol       Date:  2010-02-17       Impact factor: 4.375

4.  Sprouty2 protein in prediction of post-treatment ascites in epithelial ovarian cancer treated with adjuvant carbotaxol chemotherapy.

Authors:  Samar Masoumi-Moghaddam; Afshin Amini; Ai-Qun Wei; Gregory Robertson; David L Morris
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

5.  Targeted ovarian cancer treatment: the TRAILs of resistance.

Authors:  Nadzeya Goncharenko Khaider; Denis Lane; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  Am J Cancer Res       Date:  2011-11-21       Impact factor: 6.166

Review 6.  Impact of stress on cancer metastasis.

Authors:  Myrthala Moreno-Smith; Susan K Lutgendorf; Anil K Sood
Journal:  Future Oncol       Date:  2010-12       Impact factor: 3.404

Review 7.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

Review 8.  Neuroendocrine influences on cancer biology.

Authors:  Premal H Thaker; Anil K Sood
Journal:  Semin Cancer Biol       Date:  2007-12-08       Impact factor: 15.707

9.  Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer.

Authors:  M D Brown; C Hart; E Gazi; P Gardner; N Lockyer; N Clarke
Journal:  Br J Cancer       Date:  2009-12-08       Impact factor: 7.640

10.  Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production in vitro.

Authors:  O Toutirais; A Gervais; F Cabillic; M Le Gallo; A Coudrais; J Levêque; V Catros-Quemener; N Genetet
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.